The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Terpenoids: natural products for cancer therapy
Abstract
INTRODUCTION: Terpenoids constitute the largest class of natural products and are a rich reservoir of candidate compounds for drug discovery. Recent efforts into the research and development of anti-cancer drugs derived from natural products have led to the identification of a variety of terpenoids that inhibit cancer cell proliferation and metastasis via various mechanisms. Despite the increasing number of research reports, there lacks a comprehensive review of anti-cancer activity of terpenoids. AREAS COVERED: The present article provides an overview of the recent progress in the anti-cancer studies on terpenoids. Over a dozen naturally originated terpenoid compounds, in particular those derived from traditional Chinese medicine, were classified into five categories according to the structures, namely monoterpenoids, sesquiterpenoids, diterpenoids, triterpenoids and tetraterpenoids. The anti-cancer activities and relevant mechanistic insights of these compounds are discussed in this review. EXPERT OPINION: The anti-cancer activity of terpenoids appears promising and will potentially open more opportunities for cancer therapy. However, current studies are restricted to descriptive findings and lack mechanistic insights and systematic structure-activity relationship (SAR) studies. Future efforts into the systematic identification of the targets of terpenoids are believed to increase chances of gaining breakthrough insights in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ji, J. F., Zhang, L., Wu, Y., Zhu, X., Lv, S.-Q., & Sun, X.-Z. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/00268970600909205 · Cited by 42
RetractedMicrotubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
The function of terpene natural products in the natural world
Gershenzon, J., & Dudareva, N. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.5 · Cited by 2,167
Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use
Zhou, L., Zuo, Z., & Chow, M. S. S. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005282630 · Cited by 1,274
The role of carotenoids in the prevention of human pathologies
Tapiero, H., Townsend, D. M., & Tew, K. D. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.12.006 · Cited by 645
Blaskovich, M. A., Sun, J., Cantor, A. B., Turkson, J., Jove, R., & Sebti, S. M. (2003) · PubMed · Cited by 643
Hieronymus, H., Lamb, J., Ross, K. N., Peng, X. P., Clement, C., Rodina, A., Nieto, M., Du, J., Stegmaier, K., Raj, S. M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.005 · Cited by 624
Cancer Chemoprevention by Carotenoids
Tanaka, T., Shnimizu, M., & Moriwaki, H. (2012) · Molecules · doi:10.3390/molecules17033202 · Cited by 589
Yang, H., Chen, D., Cui, Q. C., Yuan, X., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4529 · Cited by 586
The anti-malarial artesunate is also active against cancer
Efferth, T., Dunstan, H., Sauerbrey, A., Miyachi, H., & Chitambar, C. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.4.767 · Cited by 564
XPB, a subunit of TFIIH, is a target of the natural product triptolide
Titov, D. V., Gilman, B., He, Q.-L., Bhat, S., Low, W.-K., Dang, Y., Smeaton, M., Demain, A. L., Miller, P. S., Kugel, J. F., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.522 · Cited by 509
(2007) · PubMed · Cited by 500
Molecular Modes of Action of Artesunate in Tumor Cell Lines
Efferth, T., Sauerbrey, A., Olbrich, A., Gebhart, E., Rauch, P., Weber, H. O., Hengstler, J. G., Halatsch, M.-E., Volm, M., Tew, K. D., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.382 · Cited by 428
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
Kucuk, O., Sarkar, F. H., Sakr, W., Djurić, Z., Pollak, M., Khachik, F., Li, Y. W., Banerjee, M., Grignon, D. J., Bertram, J. S., et al. (2001) · PubMed · Cited by 416
(2004) · Planta Medica · doi:10.1055/s-2004-815483 · Cited by 409
Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents
Chaturvedi, D., Goswami, A., Pratim Saikia, P., Barua, N. C., & Rao, P. G. (2010) · Chem. Soc. Rev. · doi:10.1039/b816679j · Cited by 396
Anti-cancer natural products isolated from chinese medicinal herbs
Tan, W., Lu, J., Huang, M., Li, Y., Chen, M., Wu, G., Gong, J., Zhong, Z., Xu, Z., Dang, Y., et al. (2011) · Chinese Medicine · doi:10.1186/1749-8546-6-27 · Cited by 396
Self-citationTriterpenoids as new promising anticancer drugs
Petronelli, A., Pannitteri, G., & Testa, U. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328330fd90 · Cited by 381
Xia, Y.-F., Ye, B.-Q., Li, Y.-D., Wang, J.-G., He, X.-J., Lin, X., Yao, X., Ma, D., Slungaard, A., Hebbel, R. P., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4207 · Cited by 378
Allison, A. C., Cacabelos, R., Lombardi, V. R. M., Álvarez, X. A., & Vigo, C. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00192-0 · Cited by 376
A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
Zhang, T., Hamza, A., Cao, X., Wang, B., Yu, S., Zhan, C.-G., & Sun, D. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0484 · Cited by 363
Triptolide and its expanding multiple pharmacological functions
Liu, Q. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.012 · Cited by 345
Sethi, G., Ahn, K. S., Pandey, M. K., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-10-050807 · Cited by 336
Hou, J., Wang, D., Zhang, R., & Wang, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0197 · Cited by 320
Lee, J.-H., Koo, T. H., Yoon, H., Jung, H. S., Jin, H. Z., Lee, K., Hong, Y.-S., & Lee, J. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.014 · Cited by 308
Celastrol: Molecular targets of Thunder God Vine
Salminen, A., Lehtonen, M., Paimela, T., & Kaarniranta, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.050 · Cited by 293
Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana
Jayaprakasam, B., Seeram, N. P., & Nair, M. G. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00497-4 · Cited by 291
Honkanen, R. E. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80889-3 · Cited by 287
Qiu, D., Zhao, G., Aoki, Y., Shi, L., Uyei, A., Nazarian, S., Ng, J. C.-H., & Kao, P. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13443 · Cited by 269
Lim, J. C. W., Chan, T. K., Ng, D. S., Sagineedu, S. R., Stanslas, J., & Wong, W. F. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05633.x · Cited by 268
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
Efferth, T., Benakis, A., Romero, M. R., Tomicic, M., Rauh, R., Steinbach, D., Häfer, R., Stamminger, T., Oesch, F., Kaina, B., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.023 · Cited by 266
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity
Sun, J., Blaskovich, M. A., Jove, R., Livingston, S. K., Coppola, D., & Sebti, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208470 · Cited by 263
Potential anticancer activity of tanshinone IIA against human breast cancer
Wang, X., Wei, Y., Yuan, S., Liu, G., Lu, Y., Zhang, J., & Wang, W. (2005) · International Journal of Cancer · doi:10.1002/ijc.20880 · Cited by 237
Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease
Leuenroth, S. J., Okuhara, D., Shotwell, J. D., Markowitz, G. S., Yu, Z., Somlo, S., & Crews, C. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700499104 · Cited by 236
Thoennissen, N. H., Iwanski, G. B., Doan, N. B., Okamoto, R., Lin, P., Abbassi, S., Song, J. H., Yin, D., Toh, M., Xie, W. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0536 · Cited by 234
Development of artemisinin compounds for cancer treatment
Lai, H. C., Singh, N. P., & Sasaki, T. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9873-z · Cited by 233
Trott, A., West, J. D., Klaić, L., Westerheide, S. D., Silverman, R. B., Morimoto, R. I., & Morano, K. A. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-10-1004 · Cited by 226
Triptolide, an Inhibitor of the Human Heat Shock Response That Enhances Stress-induced Cell Death
Westerheide, S. D., Kawahara, T. L. A., Orton, K., & Morimoto, R. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512044200 · Cited by 226
Antioxidant and anti-proliferative properties of lycopene
Kelkel, M., Schumacher, M., Dicato, M., & Diederich, M. (2011) · Free Radical Research · doi:10.3109/10715762.2011.564168 · Cited by 226
Chan, K. T., Meng, F. Y., Li, Q., Ho, C. Y., Lam, T. S., To, Y., Lee, W. H., Li, M., Chu, K. H., & Toh, M. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.01.029 · Cited by 222
Pang, X., Yi, Z., Zhang, J., Lu, B., Sung, B., Qu, W., Aggarwal, B. B., & Liu, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3201 · Cited by 216
Antihyperglycemic Effect of Andrographolide in Streptozotocin-Induced Diabetic Rats
(2003) · Planta Medica · doi:10.1055/s-2003-45185 · Cited by 211
Phase I and pharmacokinetic study of d -limonene in patients with advanced cancer
Vigushin, D. M., Poon, G. K., Boddy, A., English, J., Halbert, G. W., Pagonis, C., Jarman, M., & Coombes, R. C. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050793 · Cited by 198
Cucurbitacins and their pharmacological effects
Miró, M. (1995) · Phytotherapy Research · doi:10.1002/ptr.2650090302 · Cited by 194
Studies on the mechanism of skin tumor promotion.
Hennings, H., & Boutwell, R. K. (1970) · PubMed · Cited by 187
Li, W., Xie, L., Chen, Z., Zhu, Y., Sun, Y., Miao, Y., Xu, Z., & Han, X. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01523.x · Cited by 185
Anticancer activities of artemisinin and its bioactive derivatives
Firestone, G. L., & Sundar, S. N. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001239 · Cited by 185
Chen, T., Li, M., Zhang, R., & Wang, H. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00360.x · Cited by 180
Vispé, S., DeVries, L., Créancier, L., Besse, J., Bréand, S., Hobson, D. J., Svejstrup, J. Q., Annereau, J.-P., Cussac, D., Dumontet, C., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0549 · Cited by 176
Canene-Adams, K., Lindshield, B. L., Wang, S., Jeffery, E. H., Clinton, S. K., & Erdman, J. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3462 · Cited by 175
Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment
Lee, D. H., Iwanski, G. B., & Thoennissen, N. H. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.44 · Cited by 164
Triptolide and Chemotherapy Cooperate in Tumor Cell Apoptosis
Chang, W.-T., Kang, J. J., Lee, K.-Y., Wei, K., Anderson, E., Gotmare, S., Ross, J. A., & Rosen, G. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009713200 · Cited by 164
Dihydroartemisinin is an inhibitor of ovarian cancer cell growth
Jiao, Y., Ge, C., Meng, Q., Cao, J., Tong, J., & Fan, S. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00612.x · Cited by 163
Wang, S.-J., Gao, Y., Chen, H., Kong, R., Jiang, H.-C., Pan, S.-H., Xue, D.-B., Bai, X.-W., & Sun, B. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.01.001 · Cited by 163
Willoughby, J. A., Sundar, S. N., Cheung, M., Tin, A. S., Modiano, J., & Firestone, G. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804491200 · Cited by 162
Du, J.-H., Zhang, H.-D., Ma, Z.-J., & Ji, K.-M. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1095-5 · Cited by 159
The State of the Art in Anti-Malarial Drug Discovery and Development
Burrows, J. N., Chibale, K., & Wells, T. N. C. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795429194 · Cited by 157
Law, B. Y. K., Wang, M., Ma, D., Al‐Mousa, F., Michelangeli, F., Cheng, S., Ng, M. H. L., To, K., Mok, A. Y. F., Ko, R. Y. Y., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0700 · Cited by 155
Ikezoe, T., Yang, Y., Bandobashi, K., Saito, T., Takemoto, S., Machida, H., Togitani, K., Koeffler, H. P., & Taguchi, H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0277 · Cited by 154
Lycopene and Soy Isoflavones in the Treatment of Prostate Cancer
Vaishampayan, U. N., Hussain, M., Banerjee, M., Seren, S., Sarkar, F. H., Fontana, J. A., Forman, J. D., Cher, M. L., Powell, I. J., Pontes, J. E., et al. (2007) · Nutrition and Cancer · doi:10.1080/01635580701413934 · Cited by 143
Inhibition of tumor progression by naturally occurring terpenoids
Kuttan, G., Pratheeshkumar, P., Manu, K. A., & Kuttan, R. (2011) · Pharmaceutical Biology · doi:10.3109/13880209.2011.559476 · Cited by 143
Celastrol inhibits pro-inflammatory cytokine secretion in Crohn’s disease biopsies
Pinna, G., Fiorucci, M., Reimund, J., Taquet, N., Arondel, Y., & Muller, C. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.186 · Cited by 141
Cui, Y., Lu, Z., Bai, L., Shi, Z., Zhao, W., & Zhao, B. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.08.015 · Cited by 140
Chen, Y., Chen, K.-H., Huang, P., Chen, Y., Chiou, G.-Y., Lo, W., Tseng, L., Hsu, H.-S., Chang, K., & Chiou, S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0504 · Cited by 138
Cytotoxic and Anti-oxidant Activities of Lanostane-Type Triterpenes Isolated from Poria cocos
Zhou, L. F., Zhang, Y., Gapter, L. A., Ling, H. Y., Agarwal, R., & Ng, K. Y. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.1459 · Cited by 126
Anticancer effects of tanshinone I in human non-small cell lung cancer
Lee, C.-Y., Sher, H.-F., Chen, H., Liu, C.-C., Chen, C., Lin, C., Yang, P., Tsay, H.-S., & Chen, J. J. W. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2288 · Cited by 126
Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo
Chen, H., Sun, B., Pan, S., Jiang, H., & Sun, X. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283212ade · Cited by 125
Antimalarial dihydroartemisinin also inhibits angiogenesis
Chen, H., Zhou, H., Wang, W., & Wu, G. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0751-4 · Cited by 125
Rivat, C., Rodrigues-Ferreira, S., Erik, B., Piétu, G., Amélie, R., Redeuilh, G., Bracke, M., Gespach, C. P., & Attoub, S. (2005) · Cancer Research · doi:10.1158/0008-5472.195.65.1 · Cited by 125
Cytotoxic Activities of Tanshinones Against Human Carcinoma Cell Lines
Wu, W.-L., Chang, W.-L., & Chen, C. (1991) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x91000284 · Cited by 123
Rasheed, S. A. K., Efferth, T., Asangani, I. A., & Allgayer, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25315 · Cited by 122
Huang, Y., Zhou, Y., Fan, Y., & Zhou, D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.043 · Cited by 122
Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos
Gapter, L. A., Wang, Z., Glinski, J., & Ng, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.044 · Cited by 121
Bishayee, A., & Rabi, T. (2009) · Journal of Carcinogenesis · doi:10.4103/1477-3163.51368 · Cited by 121
Sung, H. J., Choi, S. M., Yoon, Y., & An, K. S. (1999) · Experimental & Molecular Medicine · doi:10.1038/emm.1999.28 · Cited by 120
Lu, J., Chen, S.-M., Zhang, X., Ding, J., & Meng, L. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9481-8 · Cited by 119
Self-citationLu, J., Meng, L., Cai, Y.-J., Chen, Q., Tong, L., Lin, L., & Ding, J. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.7.6035 · Cited by 118
Self-citationYin, D., Wakimoto, N., Xing, H., Lu, D., Huynh, T. P., Wang, X. Q., Black, K. L., & Koeffler, H. P. (2008) · International Journal of Cancer · doi:10.1002/ijc.23648 · Cited by 118
Hsu, H., Huang, P., Chang, Y., Tzao, C., Chen, Y., Shih, H., Hung, S., Chen, Y., Tseng, L., & Chiou, S. (2011) · Cancer · doi:10.1002/cncr.25869 · Cited by 113
Wong, V. K. W., Chiu, P., Chung, S. S. M., Chow, L. M. C., Zhao, Y., Yang, B. B., & Ko, B. C. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0209 · Cited by 112
Rivat, C., Rivat, C., Rodrigues-Ferreira, S., Rodrigues, S., Bruyneel, E. A., Erik, B., Piétu, G., Piétu, G., Robert, A., Amélie, R., et al. (2005) · PubMed · Cited by 110
Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters
Eid, S. Y., El-Readi, M. Z., & Wink, M. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.05.010 · Cited by 110
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
Michaelis, M., Kleinschmidt, M. C., Barth, S., Rothweiler, F., Geiler, J., Breitling, R., Mayer, B., Deubzer, H. E., Witt, O., Kreuter, J., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.013 · Cited by 110
Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol
Nagase, M., Jinsei, O. T. O., SUGIYAMA, S., Yube, K., Takaishi, Y., & Sakato, N. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.1883 · Cited by 108
Clegg, R. J., Middleton, B. S., Bell, G. D., & White, D. A. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34920-2 · Cited by 106
Wang, Y., Lu, J., He, L., & Yu, Q. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023993 · Cited by 104
Self-citationPeng, B., Xu, L., Cao, F., Wei, T., Yang, C., Uzan, G., & Zhang, D. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-79 · Cited by 104
Lee, W., Liu, K. W. K., & Yeung, J. H. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.040 · Cited by 103
Hwang, Y. P., Yun, H. J., Kim, H. G., Han, E. H., Lee, G. W., & Jeong, H. G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.003 · Cited by 101
Cheng, Y., Qiu, F., Ye, Y., Guo, Z., Tashiro, S.-I., Onodera, S., & Ikejima, T. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06864.x · Cited by 99
Nizamutdinova (1992) · International Journal of Oncology · doi:10.3892/ijo_00000031 · Cited by 99
Heme Mediates Cytotoxicity from Artemisinin and Serves as a General Anti-Proliferation Target
Zhang, S., & Gerhard, G. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007472 · Cited by 96
The Effects of Cantharidin and Cantharidin Derivates on Tumour Cells
Liu, D., & Chen, Z. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520610909040392 · Cited by 95
Prieto, J. M., Recio, M. C., Giner, R. M., Máñez, S., Giner-Larza, E. M., & Rı́os, J. L. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021620 · Cited by 94
Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
Handrick, R., Ontikatze, T., Bauer, K.-D., Freier, F., Rübel, A., Dürig, J., Belka, C., & Jendrossek, V. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0051 · Cited by 94
Huang, Y.-T., Huang, D., Chueh, S., Teng, C., & Guh, J. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.02.011 · Cited by 92
Chen, M., Lin, Y., Yang, C., & Hu, M. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100683 · Cited by 92
He, Q., Shi, J., Shen, X., An, J., Sun, H., Wang, L., Hu, Y.-J., Sun, Q. Y., Fu, L., Sheikh, M. S., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.10.11552 · Cited by 91
Won, S., Lee, H., Jeong, S., Lee, H.-J., Lee, E., Jung, D., Shin, J.-M., Kwon, T., Yun, S.-M., Lee, M., et al. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1828 · Cited by 91
Li, M.-H., Miao, Z., Tan, W., Yue, J., Zhang, C., Lin, L., Zhang, X., & Ding, J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0951 · Cited by 90
Park, I.-J., Kim, M., Park, O. J., Park, M. G., Choe, W., Kang, I., Kim, S. S., & Ha, J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.06.006 · Cited by 87
Chou, C. C., Pan, S., Teng, C., & Guh, J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00144-1 · Cited by 86
Yu, X., Tao, W., Jiang, F., Li, C., Lin, J., & Liu, C. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.75 · Cited by 86
Reungpatthanaphong, P., & Mankhetkorn, S. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1555 · Cited by 86
Kim, Y., Seo, J. H., & Kim, H. (2011) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.57.216 · Cited by 85
Lee, W., Cheung, C. C. M., Liu, K. W. K., Fung, K., Wong, J., Lai, P. B. S., & Yeung, J. H. K. (2010) · Journal of Natural Products · doi:10.1021/np900792p · Cited by 83
Haritunians, T., Gueller, S., Zhang, L., Badr, R., Yin, D., Xing, H., Fung, M. C., & Koeffler, H. P. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.01.019 · Cited by 81
The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells
Mu, D., Zhang, W., Chu, D.-L., Liu, T., Xie, Y., Fu, E., & Jin, F. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0517-5 · Cited by 81
Boykin, C., Zhang, G., Chen, Y.-H., Zhang, R.-W., Fan, X.-E., Yang, W.-M., & Lu, Q. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.10 · Cited by 81
Ling, H. Y., Zhang, Y., Ng, K. Y., & Chew, E. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0929-5 · Cited by 81
Wang, Y.-J., Wang, J.-T., Fan, Q.-X., & Geng, J.-G. (2007) · Cell Research · doi:10.1038/cr.2007.89 · Cited by 80
Self-citationShi, X., Franko, B., Frantz, C., Amin, H. M., & Lai, R. L. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06259.x · Cited by 80
Iwanski, G. B., Lee, D. H., Ein-Gal, S. Y., Doan, N., Castor, B., Vogt, M., Toh, M., Bokemeyer, C., SAID, J. W., Thoennissen, N. H., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00741.x · Cited by 79
Chen, H., Sun, B., Wang, S., Pan, S., Gao, Y., Bai, X., & Xue, D. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0731-0 · Cited by 79
Lu, J., Meng, L.-H., Shankavaram, U. T., Zhu, C.-H., Tong, L.-J., Chen, G., Lin, L.-P., Weinstein, J. N., & Ding, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.016 · Cited by 75
Self-citationZhang, Y., Wu, Y., Tashiro, S., Onodera, S., & Ikejima, T. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.92 · Cited by 75
Huh, J., Kang, K., Chae, C., Kim, H., Ahn, K.-S., & Kim, S. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.025 · Cited by 72
Artemisinin antimalarials: mechanisms of action and resistance.
Meshnick, S. (1998) · PubMed · Cited by 70
Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer
Liu, T., Zhang, M., Zhang, H., Sun, C., Yang, X., Deng, Y., & Ji, W. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.032 · Cited by 69
Lui, V. W. Y., Yau, D., Wong, E. Y. L., Ng, Y., Lau, C. P. Y., Ho, Y., Chan, J., Hong, B., Ho, K., Cheung, C. S. F., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp253 · Cited by 69
Bertini, I., Calderone, V., Fragai, M., Luchinat, C., & Talluri, E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900610k · Cited by 68
Wen (2010) · Oncology Reports · doi:10.3892/or.2010.1107 · Cited by 68
Kaji, I., Tatsuta, M., Iishi, H., Baba, M., Inoue, A., & Kasugai, H. (2001) · International Journal of Cancer · doi:10.1002/ijc.1353 · Cited by 67
Protein Phosphatase 2A as a Potential Target for Anticancer Therapy
Kalev, P., & Sablina, A. A. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011794941172 · Cited by 66
Kawata, S., Nagase, T., Yamasaki, E., Ishiguro, H., & Matsuzawa, Y. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.199 · Cited by 64
Tsai, M.-Y., Yang, R.-C., Wu, H., Pang, J. S., & Huang, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.031 · Cited by 63
Zhu, H., Liu, X.-W., Cai, T.-Y., Cao, J., Tu, C.-X., Lu, W. P., He, Q.-J., & Yang, B. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.165654 · Cited by 62
Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells
Su, C. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000063 · Cited by 61
Buommino, E., Baroni, A., Canozo, N., Petrazzuolo, M., Nicoletti, R., VOZZA, A., & Tufano, M. A. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9188-2 · Cited by 61
Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios
Su, C. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000030 · Cited by 60
Tripterine inhibits the expression of adhesion molecules in activated endothelial cells
Zhang, D., Marconi, A., Xu, L., Yang, C., Sun, G.-W., Feng, X., Ling, C., Qin, W.-Z., Uzan, G., & d’Alessio, P. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005611 · Cited by 60
Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells
Hua, Z. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1210 · Cited by 59
Growth Inhibition and Apoptosis Induction by Tanshinone IIA in Human Colon Adenocarcinoma Cells
Su, C., Chen, G., Kang, J., & Chan, M. (2008) · Planta Medica · doi:10.1055/s-2008-1081299 · Cited by 58
Ishdorj, G., Johnston, J. B., & Gibson, S. B. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0550 · Cited by 57
Zhang, M., Sun, C., Shan, X., Yang, X., Li‐Ling, J., & Deng, Y. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ce719e · Cited by 54
Andrographolide Inhibits Oral Squamous Cell Carcinogenesis through NF-κB Inactivation
Wang, L.-J., Zhou, X., Wang, W., Tang, F., Qi, C., Yang, X., Wu, S., Lin, Y., Wang, J.-T., & Geng, J. (2011) · Journal of Dental Research · doi:10.1177/0022034511418341 · Cited by 53
Ling, H. Y., Jia, X., Zhang, Y., Gapter, L. A., Lim, Y., Agarwal, R., & Ng, K. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20597 · Cited by 52
Li, S., Xue, F., Cheng, Z., Yang, X., Wang, S., Geng, F., & Pan, L. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0409-z · Cited by 52
Cucurbitacin I Inhibits Cell Motility by Indirectly Interfering with Actin Dynamics
Knecht, D. A., LaFleur, R. A., Kahsai, A. W., Argueta, C. E., Beshir, A. B., & Fenteany, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014039 · Cited by 51
Li, W., Chen, Z., Zong, Y., Gong, F., Zhu, Y., Zhu, Y., Lv, J., Zhang, J., Xie, L., Sun, Y., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.009 · Cited by 51
Huang, C., Chuang, C., Lo, T.-F., & Hu, M. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.01.003 · Cited by 45
Factors determining sensitivity or resistance of tumor cell lines towards artesunate
Sertel, S., Eichhorn, T., Sieber, S., Sauer, A., Weiß, J., Plinkert, P. K., & Efferth, T. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.02.002 · Cited by 43
Yu, J., Wang, H., Li, X., Tashiro, S., Onodera, S., & Ikejima, T. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00835.x · Cited by 42
Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells
Dai, Z.-K., Qin, J., Huang, J.-E., Luo, Y., Xu, Q. R., & Zhao, H. (2011) · Journal of Natural Medicines · doi:10.1007/s11418-011-0576-0 · Cited by 41
Tan, W., Zhang, X., Li, M.-H., Yue, J., Chen, Y., Lin, L., & Ding, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.063 · Cited by 40
Yahong, Zhang, C. X., Ying-liang, et al. (2011) · 中国药理学报:英文版 · Cited by 40
Lycopene inhibits angiogenesis in human umbilical vein endothelial cells and rat aortic rings
Elgass, S., Cooper, A., & Chopra, M. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511005800 · Cited by 39
Zhou, Z.-L., Luo, Z.-G., Yu, B., Jiang, Y., Chen, Y., Feng, J.-M., Dai, M., Tong, L.-J., Li, Z., Li, Y.-C., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-268 · Cited by 38
Tang, J., Kong, X., Banerjee, A., Muniraj, N., Pandey, V., Steiner, M., Perry, J. K., Zhu, T., Liu, D., & Lobie, P. E. (2010) · Endocrinology · doi:10.1210/en.2010-0273 · Cited by 36
Triptolide binds covalently to a 90 kDa nuclear protein. Role of epoxides in binding and activity
McCallum, C. D., Kwon, S., Leavitt, P. S., Shen, D., Liu, W., & Gurnett, A. M. (2007) · Immunobiology · doi:10.1016/j.imbio.2007.02.002 · Cited by 35
Direct interaction of Cucurbitacin E isolated from Alsomitra macrocarpa to actin filament
Momma, K., Masuzawa, Y., Nakai, N., Chujo, M., Murakami, A., Kioka, N., Kiyama, Y., Akita, T., & Nagao, M. (2007) · Cytotechnology · doi:10.1007/s10616-007-9100-5 · Cited by 35
Li, Y., Wang, R., Ma, E., Deng, Y., Wang, X., Xiao, J., & Jing, Y. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328336b383 · Cited by 33
Ouyang, D., Zhang, Y.-T. Y., Xu, L., Li, J., Zha, Q., & He, X. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr032 · Cited by 31
Actin-Aggregating Cucurbitacins from Physocarpus capitatus
Maloney, K. N., Fujita, M., Eggert, U., Schroeder, F. C., Field, C. M., Mitchison, T. J., & Clardy, J. (2008) · Journal of Natural Products · doi:10.1021/np8005259 · Cited by 29
Seo, W. Y., Ju, S. M., Song, H. Y., Goh, A. R., Jun, J., Kang, Y., Choi, S. Y., & Park, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.053 · Cited by 29
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line
Lu, J., Chen, S.-M., Ding, J., et al. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1072-2 · Cited by 24
Self-citationLiu, R., Dong, H., & Jiang, M.-S. (2011) · Parasitology Research · doi:10.1007/s00436-011-2707-7 · Cited by 24
Yu, J., Li, X., Tashiro, S., Onodera, S., & Ikejima, T. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08091fp · Cited by 24
Aparicio, L. M. A., Pulido, E. G., & Gallego, G. A. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834d237b · Cited by 23
Cited by
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.014 · Cited by 390
Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis
Gali-Muhtasib, H., Hmadi, R., Kareh, M., Tohme, R., & Darwiche, N. (2015) · Apoptosis · doi:10.1007/s10495-015-1169-2 · Cited by 293
Therapeutic Potential of Volatile Terpenes and Terpenoids from Forests for Inflammatory Diseases
Kim, T., Song, B., Cho, K. S., & Lee, I.-S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062187 · Cited by 281
Therapeutic potential of ectopic olfactory and taste receptors
Lee, S.-J., Depoortere, I., & Hatt, H. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0002-3 · Cited by 279
Human Olfactory Receptors: Novel Cellular Functions Outside of the Nose
Maßberg, D., & Hatt, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00013.2017 · Cited by 262
Metadata
- Authors
- Huang, M., Lu, J.-J., Huang, M.-Q., Bao, J.-L., Chen, X.-P., & Wang, Y.-T.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2012-10-23
- Volume
- 21
- Issue
- 12
- Pages
- 1801-1818
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2001641583
- Cited by
- 333
- References
- 160
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.